AFYA 📈 Afya - Overview

Exchange: NASDAQ • Country: Brazil • Currency: USD • Type: Common Stock • ISIN: KYG011251066

AFYA: Medical Education, Online Courses, Health Services, Software Solutions

Afya Limited operates as a medical education group in Brazil. The company operates through three segments: Undergrad, Continuing Education, and Digital Services. It offers educational products and services, including medical schools, medical residency preparatory courses, graduate courses, and other programs to lifelong medical learners enrolled across its distribution network, as well as to third-party medical schools. The company provides digital health services, such as subscription-based mobile app and website portal that focuses on assisting health professionals and students with clinical decision-making through tools, such as medical calculators, charts, and updated content, as well as prescriptions, clinical scores, medical procedures and laboratory exams, and others. It offers health sciences courses, which comprise medicine, dentistry, nursing, radiology, psychology, pharmacy, physical education, physiotherapy, nutrition, and biomedicine; and degree programs and courses in other subjects and disciplines, including undergraduate and post graduate courses in business administration, accounting, law, civil engineering, industrial engineering, and pedagogy. In addition, the company provides medical postgraduate specialization programs; printed and digital content; and an online medical education platform and practical medical training services. Further, it offers iClinic, a practice management software; educational health and medical imaging solutions through an interactive platform; Cliquefarma, a free-to-use website that tracks prescription drugs, cosmetics and personal hygiene product prices; Shosp, a clinical management software; RX PRO, a solution that connects physicians with the pharmaceutical industry; and Glic, a free diabetes care and management app solution for physicians and patients. The company was founded in 1999 and is headquartered in Nova Lima, Brazil. Web URL: https://www.afya.com.br

Additional Sources for AFYA Stock

AFYA Stock Overview

Market Cap in USD 1,387m
Sector Consumer Defensive
Industry Education & Training Services
GiC Sub-Industry Education Services
IPO / Inception 2019-07-19

AFYA Stock Ratings

Growth 5y -56.3%
Fundamental 79.7%
Dividend -
Rel. Strength Industry -194
Analysts 3.33/5
Fair Price Momentum 12.96 USD
Fair Price DCF 492.46 USD

AFYA Dividends

No Dividends Paid

AFYA Growth Ratios

Growth Correlation 3m -51.8%
Growth Correlation 12m -77.6%
Growth Correlation 5y -48.7%
CAGR 5y -10.85%
CAGR/Mean DD 5y -0.28
Sharpe Ratio 12m -0.93
Alpha -54.10
Beta 0.97
Volatility 39.70%
Current Volume 118.4k
Average Volume 20d 121.6k
What is the price of AFYA stocks?
As of December 21, 2024, the stock is trading at USD 15.50 with a total of 118,410 shares traded.
Over the past week, the price has changed by -0.90%, over one month by -5.26%, over three months by -5.49% and over the past year by -27.60%.
Is Afya a good stock to buy?
Yes, based on ValueRay Fundamental Analyses, Afya (NASDAQ:AFYA) is currently (December 2024) a good stock to buy. It has a ValueRay Fundamental Rating of 79.66 and therefor a positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of AFYA as of December 2024 is 12.96. This means that AFYA is currently overvalued and has a potential downside of -16.39%.
Is AFYA a buy, sell or hold?
Afya has received a consensus analysts rating of 3.33. Therefor, it is recommend to hold AFYA.
  • Strong Buy: 1
  • Buy: 2
  • Hold: 5
  • Sell: 1
  • Strong Sell: 0
What are the forecast for AFYA stock price target?
According to ValueRays Forecast Model, AFYA Afya will be worth about 14.2 in December 2025. The stock is currently trading at 15.50. This means that the stock has a potential downside of -8.52%.
Issuer Forecast Upside
Wallstreet Target Price 19.2 23.8%
Analysts Target Price 21.5 38.5%
ValueRay Target Price 14.2 -8.5%